Factors that influence the decision include: baseline IGF-1 (lower IGF-1 may favor sermorelin to start), metabolic syndrome status (favors tesamorelin), visceral adiposity (favors tesamorelin), prior response to growth hormone-releasing peptides (helps calibrate dose), and patient tolerance preferences
"So, I would say it's been a complete flip in our practice," said Dr
It's just too aggressive and risks physically damaging the compound before it even has a chance to dissolve
Moreover, CICR requires continual activation of VDCCs by Ca 2+ within intracellular microdomains, but not by robust Ca 2+ influx from extracellular spaces [8,15,17,24]
Carmody M, Waszczak C, Idnheimo N, Saarinen T, Kangasjrvi J (2016) ROS signalling in a destabilised world: a molecular understanding of climate change